NKGen (fka. NK Max) (Pre-Seed)

Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$300,000,000

Company Info
Founders
Stephen Chen
Company Description
Restoring immune function through the development of unique natural killer (NK) cell therapies. NKGen Biotech is restoring immune function through the development of unique natural killer (NK) cell therapies for the treatment of cancer.
Market
Healthcare & Wellness

Links
Back to Home Back to Healthcare and Biotech Deals View Funding Announcement